Sutro Biopharma, Inc. (STRO)
21.39
+0.90
(+4.39%)
USD |
NASDAQ |
Aug 25, 16:00
21.39
0.00 (0.00%)
After-Hours: 19:59
Sutro Biopharma Market Cap : 354.56M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 339.65M |
| August 21, 2026 | 348.76M |
| August 20, 2026 | 350.75M |
| August 19, 2026 | 363.18M |
| August 18, 2026 | 365.34M |
| August 17, 2026 | 369.32M |
| August 14, 2026 | 339.48M |
| August 13, 2026 | 353.24M |
| August 12, 2026 | 353.07M |
| August 11, 2026 | 415.07M |
| August 10, 2026 | 423.19M |
| August 07, 2026 | 420.70M |
| August 06, 2026 | 400.09M |
| August 05, 2026 | 415.83M |
| August 04, 2026 | 425.27M |
| August 03, 2026 | 415.83M |
| July 31, 2026 | 400.42M |
| July 30, 2026 | 411.19M |
| July 29, 2026 | 386.34M |
| July 28, 2026 | 393.13M |
| July 27, 2026 | 397.77M |
| July 24, 2026 | 379.05M |
| July 23, 2026 | 390.98M |
| July 22, 2026 | 387.66M |
| July 21, 2026 | 381.04M |
| Date | Value |
|---|---|
| July 20, 2026 | 374.24M |
| July 17, 2026 | 390.48M |
| July 16, 2026 | 393.13M |
| July 15, 2026 | 430.74M |
| July 14, 2026 | 431.23M |
| July 13, 2026 | 461.22M |
| July 10, 2026 | 492.53M |
| July 09, 2026 | 496.84M |
| July 08, 2026 | 527.49M |
| July 07, 2026 | 532.29M |
| July 06, 2026 | 507.44M |
| July 02, 2026 | 504.13M |
| July 01, 2026 | 500.98M |
| June 30, 2026 | 550.02M |
| June 29, 2026 | 552.50M |
| June 26, 2026 | 505.62M |
| June 25, 2026 | 489.55M |
| June 24, 2026 | 497.50M |
| June 23, 2026 | 483.58M |
| June 22, 2026 | 522.68M |
| June 18, 2026 | 490.87M |
| June 17, 2026 | 470.66M |
| June 16, 2026 | 466.69M |
| June 15, 2026 | 500.32M |
| June 12, 2026 | 477.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Praxis Precision Medicines, Inc. | 10.26B |
| Upstream Bio, Inc. | 393.26M |
| ACADIA Pharmaceuticals, Inc. | 5.264B |
| Alnylam Pharmaceuticals, Inc. | 32.09B |
| Anika Therapeutics, Inc. | 288.00M |
Market Cap Related Metrics
| PS Ratio | 5.467 |
| PEG Ratio | -0.0248 |
| Price | 21.39 |
| Earnings Yield | -81.41% |
| PEGY Ratio | -0.0248 |